Literature DB >> 19003389

Justification of continuous packed-bed reactor for retroviral vector production from amphotropic PsiCRIP murine producer cell.

S H Kang1, B G Kim, G M Lee.   

Abstract

To indentify a plausible large-scale production system forretroviral vector, three culture systems, i.e., batch culturewith medium exchange, microcarrier culture, and packed-bedreactor culture were compared. In batch cultures with mediumexchange, high cell concentrations were maintained for about amonth, and the harvested retroviral titer remained constant. Inmicrocarrier cultures, although cell growth was rapid, theretroviral titer was unexpectedly low, suggesting that the lowtiter was due either to serious damage to the retroviral vectoror to a reduction in the production rate of retroviral vector,caused by mechanical shear forces. Although the retroviral titer(maximum titer, 1.56 x 10(6)) in the packed-bedreactor was a little bit lower than that obtained in the batchculture with medium exchange (maximum titer, 1.91 x10(6)), continuous production made it possible to increasethe cumulative titer up to 16-fold of that from the batchculture with medium exchange. Moreover, as the packed-bedreactor system requires less labor and shows excellentvolumetric productivity in comparison to batch cultures withmedium exchanges, it will be an appropriate production systemfor retroviral vector in large quantities.

Entities:  

Year:  2000        PMID: 19003389      PMCID: PMC3449741          DOI: 10.1023/A:1008120313175

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  22 in total

1.  Fixed bed porous glass sphere (porosphere) bioreactors for animal cells.

Authors:  D Looby; J B Griffiths
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

2.  Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers.

Authors:  A S Chuck; B O Palsson
Journal:  Hum Gene Ther       Date:  1996-04-10       Impact factor: 5.695

3.  Production of increased titer retrovirus vectors from stable producer cell lines by superinfection and concentration.

Authors:  M K Parente; J H Wolfe
Journal:  Gene Ther       Date:  1996-09       Impact factor: 5.250

4.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

Authors:  D S Ory; B A Neugeboren; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Viral vector systems for gene therapy.

Authors:  D Jolly
Journal:  Cancer Gene Ther       Date:  1994-03       Impact factor: 5.987

6.  A microcarrier cell culture system for large scale production of hepatitis A virus.

Authors:  A Widell; B G Hansson; E Nordenfelt
Journal:  J Virol Methods       Date:  1984-02       Impact factor: 2.014

7.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector.

Authors:  T Ohashi; S Boggs; P Robbins; A Bahnson; K Patrene; F S Wei; J F Wei; J Li; L Lucht; Y Fei
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Optimization of environmental factors for the production and handling of recombinant retrovirus.

Authors:  S G Lee; S Kim; P D Robbins; B G Kim
Journal:  Appl Microbiol Biotechnol       Date:  1996-05       Impact factor: 4.813

10.  Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.

Authors:  J R Sanes; J L Rubenstein; J F Nicolas
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  1 in total

1.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.